Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Juniper Research Ltd | PRODUCT CODE: 1066075

Cover Image

PUBLISHER: Juniper Research Ltd | PRODUCT CODE: 1066075

Digital Therapeutics & Wellness: Key Trends, Business Models & Market Forecasts 2022-2026

PUBLISHED:
PAGES:
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
Web Access - Competitor Leaderboard (Enterprise Wide License)
USD 2567.10
Web Access - Market Trends & Strategies (Enterprise Wide License)
USD 2567.10
Web Access - Market Data & Forecasting (Enterprise Wide License)
USD 3857.10
Web Access - Full Research Suite (Enterprise Wide License)
USD 4837.50

Add to Cart

Juniper Research's “Digital Therapeutics & Wellness ” research includes a complete evaluation of the key drivers, trends, and challenges facing the digital therapeutics and wellness market. These are allied to a set of comprehensive 5-year forecasts and an in-depth assessment of the disruptive potential and market strategies of the leading digital therapeutics players.

The research suite includes:

  • 1. Market Trends & Strategies: Strategic analysis of key market dynamics and opportunities, together with a detailed analysis of the digital therapeutics and wellness value chain (PDF).
  • 2. Market Data & Forecasting: In-depth forecasts for market size and growth, including number of people using digital therapeutics, number of consumer wellness apps in use, number of employees enrolled in corporate wellness schemes, and total revenue (PDF).
  • 3. Competitor Leaderboard: Leading digital therapeutics vendors assessed and scored in our Competitor Leaderboard, underpinned by interviews with players and robust scoring methodologies (PDF).
  • 4. Interactive Forecast Excel: Highly granular dataset comprising more than 96,000 datapoints; allied to an Interactive Scenario tool; giving users the ability to manipulate Juniper Research's data (Interactive XL).
  • 5. harvest Online Data Platform: 12 months' access to the report's data in our online data platform, including continuous data updates and exportable charts, tables and graphs (Online).

Table of Contents

Market Trends & Strategies

1. Key Takeaways & Strategic Recommendations

  • 1.1 Digital Therapeutics
    • 1.1.1 Key Takeaways
    • 1.1.2 Strategic Recommendations
  • 1.2 Digital Wellness
    • 1.2.1 Key Takeaways
    • 1.2.2 Strategic Recommendations

2. Research Introduction

  • 2.1 Introduction
  • 2.2 Definitions
    • 2.2.1 Digital Therapeutics
    • 2.2.2 Digital Wellness
      • Figure 2.1: Segment Overlap of Digital Wellness and Digital Therapeutics
  • 2.3 Research Scope

3. Market Dynamics

  • 3.1 Digital Therapeutics
    • 3.1.1 Improved Healthcare Delivery & Interoperability
      • Figure 3.1: Number of People Using Digital Therapeutics (m), Split by 8 Key Regions, 2022-2026
    • 3.1.2 Scientific Validation & Regulatory Approval
      • i. Deregulation in the US Due to COVID-19
    • 3.1.3 Artificial Intelligence & Machine Learning
      • i. Chatbot Complexity & the Uncanny Valley
    • 3.1.4 Growing Prevalence of Chronic Conditions
      • Figure 3.2: Number of People Using Digital Therapeutics (m), Split by Addressed Condition, 2026
  • 3.2 Digital Wellness
    • 3.2.1 Corporate Wellness
    • 3.2.2 Wider Market Appeal & Benefits
      • Figure 3.3: Total Revenue from Corporate Wellness Programmes ($m), Split by Key 8 Regions, 2022-2026
    • 3.2.3 Sales Channels & Diversification
    • 3.2.4 User Privacy & Trust

4. Value Chain & Business Models

  • 4.1 Digital Therapeutics
    • 4.1.1 Value Chain
      • i. Digital Therapeutics Vendors
      • ii. Systems Integrators
      • iii. Health Regulators
      • iv. Clinicians and Employers
      • v. Health Insurers
      • vi. End Users
        • Figure 4.1: Digital Therapeutics Value Chain
    • 4.1.2 Business Models
      • i. Digital Therapeutics Vendors
        • Figure 4.2: Total Digital Therapeutics Revenue ($m), Split by Payer, 2026
      • ii. Systems Integrators
      • iii. Health Insurers
  • 4.2 Digital Wellness
    • 4.2.1 Value Chain
      • i. Digital Wellness Vendors
      • ii. Employers
      • iii. Health Insurers
      • iv. Consumers
        • Figure 4.3: Digital Wellness Value Chain
    • 4.2.2 Business Models
      • i. Digital Wellness Vendors
      • ii. Health Insurers

Competitor Leaderboard

1. Juniper Research Leaderboard

  • 1.1 Why Read This Report
    • Table 1.1: Juniper Research Leaderboard: Featured Vendors & Conditions Addressed by Product Portfolio
    • Figure 1.2: Juniper Research Leaderboard: Digital Therapeutics Vendors
    • Table 1.3: Juniper Research Leaderboard: Digital Therapeutics Vendor Positioning
    • Table 1.4: Juniper Research Leaderboard Heatmap: Digital Therapeutics Vendors
  • 1.2 Leaderboard Assessment Methodology
    • 1.2.1 Limitations & Interpretations

2. Vendor Profiles

  • 2.1 2Morrow
    • i. Corporate
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
      • Figure 2.1: Advertisement for 2Morrow's Smoking Cessation Programme
    • iv. High-level View of Offerings
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 2.2 Big Health
    • i. Corporate
      • Table 2.2: Investor Funding Received by Big Health, 2014-2022
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
      • Figure 2.3: Sleepio UI
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 2.3 Click Therapeutics
    • i. Corporate
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
      • Table 2.4: Investor Funding Received by Click Therapeutics, 2012-2021
    • iv. High-level View of Offerings
      • Table 2.5: Current Status of Click Therapeutics' Product Pipeline
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 2.4 Happify Health
    • i. Corporate
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
      • Figure 2.6: Ensemble UI
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 2.5 Headspace Health
    • i. Corporate
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
      • Figure 2.7: Headspace UI
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 2.6 Kaia Health
    • i. Corporate
      • Table 2.8: Investor Funding Received by Kaia Health, 2016-2021
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
      • Figure 2.9: Kaia MSK Therapy UI
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 2.7 Livongo
    • i. Corporate
      • Table 2.10: Teladoc Health Financial Snapshot ($m), FY 2019-2021 (FYE 31 December)
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
      • Figure 2.11: Livongo's AI+AI System
  • 2.8 my mhealth
    • i. Corporate
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
      • Figure 2.12: myCOPD UI
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 2.9 Omada Health
    • i. Corporate
    • ii. Geographic Spread
      • Table 2.13: Investor Funding Received by Omada Health, 2011-2020
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
      • Figure 2.14: Omada Insights Lab
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 2.10 Pear Therapeutics
    • i. Corporate
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
      • Table 2.15: Current Status of Pear Therapeutics' Product Pipeline
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
      • Figure 2.16: reSET UI
  • 2.11 Sidekick Health
    • i. Corporate
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 2.12 Vida Health
    • i. Corporate
    • ii. Geographic Spread
      • Table 2.17: Investor Funding Received by Vida Health, 2014-2021
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
      • Figure 2.18: Vida Health UI
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 2.13 Voluntis
    • i. Corporate
      • Table 2.19: Voluntis Financial Snapshot ($m), FY 2018-2020 (FYE 31 December)
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
      • Figure 2.20: Oleena UI
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 2.14 Wise Therapeutics
    • i. Corporate
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
      • Figure 2.21: Personal Zen UI
      • Table 2.22: Wise Therapeutics' Current Product Pipeline
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 2.15 Welldoc
    • i. Corporate
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
      • Figure 2.23: Bluestar for Diabetes UI

Data & Forecasting Table of Contents

1. Research Introduction

  • 1.1 Introduction
  • 1.2 Definitions
    • 1.2.1 Digital Therapeutics
    • 1.2.2 Digital Wellness
      • Figure 1.1: Segment Overlap of Digital Wellness and Digital Therapeutics
  • 1.3 Research Scope

2. Market Summary: Digital Therapeutics & Wellness

  • 2.1 Market Summary
    • 2.1.1 Number of People Using Digital Therapeutics & Wellness Products
      • Figure & Table 2.1: Number of People Using Digital Therapeutics & Wellness Products (m), Split by 8 Key Regions, 2021-2026
      • Table 2.2: Number of People Using Digital Therapeutics & Wellness Products (m), Split by Market, 2021-2026
      • Table 2.3: Number of People Using Digital Therapeutics & Wellness Products (m), Split by Business Model, 2021-2026
    • 2.1.2 Total Digital Therapeutics & Wellness Revenue
      • Figure 2.4: Total Digital Therapeutics & Wellness Revenue ($m), Split by 8 Key Regions, 2021-2026
      • Table 2.5: Total Digital Therapeutics & Wellness Revenue ($m), Split by Market, 2021-2026
      • Table 2.6: Total Digital Therapeutics & Wellness Revenue ($m), Split by Business Model, 2021-2026

3. Market Overview: Digital Therapeutics

  • 3.1 Introduction
  • 3.2 Methodology & Assumptions
    • 3.2.1 Number of People Using Digital Therapeutics
    • 3.2.2 Total Digital Therapeutics Revenue
      • Figure 3.1: Digital Therapeutics Forecast Methodology
  • 3.3 Market Summary
    • 3.3.1 Number of People Using Digital Therapeutics
      • Figure & Table 3.2: Number of People Using Digital Therapeutics (m), Split by 8 Key Regions, 2021-2026
    • 3.3.2 Total Digital Therapeutics Revenue
      • Figure & Table 3.3: Total Digital Therapeutics Revenue ($m), Split by 8 Key Regions, 2021-2026
      • Table 3.4: Total Digital Therapeutics Revenue ($m), Split by Payer, 2021-2026
  • 3.4 Segment Market Forecasts
    • 3.4.1 Asthma & COPD
      • i. Number of People Using Digital Therapeutics to Manage Asthma & COPD
        • Figure & Table 3.5: Number of People Using Digital Therapeutics to Manage Asthma & COPD (000's), Split by 8 Key Regions, 2021-2026
        • Table 3.6: Number of People Using Digital Therapeutics to Manage Asthma & COPD (000's), Split by Payer, 2021-2026
      • ii. Total Asthma & COPD Digital Therapeutics Revenue
        • Figure & Table 3.7: Total Asthma & COPD Digital Therapeutics Revenue ($m), Split by 8 Key Regions, 2021-2026
        • Table 3.8: Total Asthma & COPD Digital Therapeutics Revenue ($m), Split by Payer, 2021-2026
    • 3.4.2 CVD & Hypertension
      • i. Number of People Using Digital Therapeutics to Manage CVD & Hypertension
        • Figure & Table 3.9: Number of People Using Digital Therapeutics to Manage CVD & Hypertension (000's), Split by 8 Key Regions, 2021-2026
        • Table 3.10: Number of People Using Digital Therapeutics to Manage CVD & Hypertension (000's), Split by Payer, 2021-2026
      • ii. Total CVD & Hypertension Digital Therapeutics Revenue
        • Figure & Table 3.11: Total CVD & Hypertension Digital Therapeutics Revenue ($m), Split by 8 Key Regions, 2021-2026
        • Table 3.12: Total CVD & Hypertension Digital Therapeutics Revenue ($m), Split by Payer, 2021-2026
    • 3.4.3 Diabetes
      • i. Number of People Using Digital Therapeutics to Manage Diabetes
        • Figure & Table 3.13: Number of People Using Digital Therapeutics to Manage Diabetes (000's), Split by 8 Key Regions, 2021-2026
        • Table 3.14: Number of People Using Digital Therapeutics to Manage Diabetes (000's), Split by Payer, 2021-2026
      • ii. Total Diabetes Digital Therapeutics Revenue
        • Figure & Table 3.15: Total Diabetes Digital Therapeutics Revenue ($m), Split by Key Regions, 2021-2026
        • Table 3.16: Total Diabetes Digital Therapeutics Revenue ($m), Split by Payer, 2021-2026
    • 3.4.4 Physical Therapy
      • i. Number of People Who Receive Physical Therapy via Digital Therapeutics
        • Figure & Table 3.17: Number of People Who Receive Physical Therapy via Digital Therapeutics (000's), Split by 8 Key Regions, 2021-2026
        • Table 3.18: Number of People Who Receive Physical Therapy via Digital Therapeutics (000's), Split by Payer, 2021-2026
      • ii. Total Physical Therapy Digital Therapeutics Revenue
        • Figure & Table 3.19: Total Physical Therapy Digital Therapeutics Revenue ($m), Split by 8 Key Regions, 2021-2026
        • Table 3.20: Total Physical Therapy Digital Therapeutics Revenue ($m), Split by Payer, 2021-2026
    • 3.4.5 Smoking Cessation
      • i. Number of People Using Digital Therapeutics to Quit Smoking
        • Figure & Table 3.21: Number of People Using Digital Therapeutics to Quit Smoking (000's), Split by 8 Key Regions, 2021-2026
        • Table 3.22: Number of People Using Digital Therapeutics to Quit Smoking (000's), Split by Payer, 2021-2026
      • ii. Total Smoking Cessation Digital Therapeutics Revenue
        • Figure & Table 3.23: Total Smoking Cessation Digital Therapeutics Revenue ($m), Split by 8 Key Regions, 2021-2026
        • Table 3.24: Total Smoking Cessation Digital Therapeutics Revenue ($m), Split by Payer, 2021-2026
    • 3.4.6 Weight Management
      • i. Number of Obese or Overweight Adults Using Digital Therapeutics Manage Their Weight
        • Figure & Table 3.25: Number of Obese or Overweight Adults Using Digital Therapeutics to Manage Their Weight (000's), Split by 8 Key Regions, 2021-2026
        • Table 3.26: Number of Obese or Overweight Adults Using Digital Therapeutics Manage Their Weight (000's), Split by Payer, 2021-2026
      • ii. Total Weight Management Digital Therapeutics Revenue
        • Figure & Table 3.27: Total Weight Management Digital Therapeutics Revenue ($m), Split by 8 Key Regions, 2021-2026
        • Table 3.28: Total Weight Management Digital Therapeutics Revenue ($m), Split by Payer, 2021-2026

4. Market Overview: Digital Wellness

  • 4.1 Introduction
  • 4.2 Methodology & Assumptions
    • 4.2.1 Consumer Wellness
      • i. Number of People Using Digital Wellness Apps
      • ii. Number of Digital Wellness Apps in Use
      • iii. Number of Digital Wellness Apps That Are Monetised via Subscription Plans
      • iv. Total Consumer Digital Wellness Revenue
        • Figure 4.1: Consumer Digital Wellness Forecast Methodology
    • 4.2.2 Corporate Wellness
      • i. Number of Employees Enrolled in Corporate Wellness Programs
      • ii. Total Corporate Wellness Revenue
        • Figure 4.2: Corporate Digital Wellness Forecast Methodology
  • 4.3 Market Summary
    • 4.3.1 Number of People Using Digital Wellness Products
      • Figure & Table 4.3: Number of People Using Digital Wellness Products (m), Split by 8 Key Regions, 2021-2026
    • 4.3.2 Total Digital Wellness Revenue
      • Figure & Table 4.4: Total Digital Wellness Revenue ($m), Split by 8 Key Regions, 2021-2026
      • Table 4.5: Total Digital Wellness Revenue ($m), Split by Market Segment, 2021-2026
  • 4.4 Segment Market Forecasts
    • 4.4.1 Consumer Wellness
      • i. Number of People Using Digital Wellness Apps
        • Figure & Table 4.6: Number of People Using Digital Wellness Apps (m), Split by Key Regions, 2021-2026
      • ii. Number of Digital Wellness Apps in Use
        • Figure & Table 4.7: Number of Digital Wellness Apps in Use (m), Split by 8 Key Regions, 2021-2026
      • iii. Number of Digital Wellness Apps that Are Monetised via Subscription Plans
        • Figure & Table 4.8: Number of Digital Wellness Apps that Are Monetised via Subscription Plans (m), Split by 8 Key Regions, 2021-2026
      • iv. Total Consumer Digital Wellness Revenue
        • Figure & Table 4.9: Total Digital Wellness Revenue ($m), Split by 8 Key Regions, 2021-2026
    • 4.4.2 Corporate Wellness
      • i. Number of Employees Enrolled in Corporate Wellness Programmes
        • Figure & Table 4.10: Number of Employees Enrolled in Corporate Wellness Programmes (m), Split by 8 Key Regions, 2021-2026
      • ii. Total Corporate Digital Wellness Revenue
        • Figure & Table 4.11: Total Corporate Wellness Revenue ($m), Split by 8 Key Regions, 2021-2026
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!